Sreenivasa Murthy

785 total citations · 1 hit paper
8 papers, 100 citations indexed

About

Sreenivasa Murthy is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sreenivasa Murthy has authored 8 papers receiving a total of 100 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 1 paper in Pharmacology and 1 paper in Pediatrics, Perinatology and Child Health. Recurrent topics in Sreenivasa Murthy's work include Diabetes Management and Research (5 papers), Diabetes Treatment and Management (4 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers). Sreenivasa Murthy is often cited by papers focused on Diabetes Management and Research (5 papers), Diabetes Treatment and Management (4 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers). Sreenivasa Murthy collaborates with scholars based in India, Denmark and United States. Sreenivasa Murthy's co-authors include Björg Ásbjörnsdóttir, Julio Rosenstock, Wendy Lane, Harpreet S. Bajaj, Chantal Mathieu, Jothydev Kesavadev, Ashu Rastogi, Rajesh Rajput, Federico Pérez Manghi and Surendra K. Sharma and has published in prestigious journals such as The Lancet, Diabetes & Metabolic Syndrome Clinical Research & Reviews and PharmacoEconomics - Open.

In The Last Decade

Sreenivasa Murthy

6 papers receiving 99 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial

2023 86 citations Chantal Mathieu, Björg Ásbjörnsdóttir et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sreenivasa Murthy India	3	93	33	28	7	6	8	100
David Huffman United States	3	54 0.6×	50 1.5×	14 0.5×	9 1.3×		4	59
Virginia Visco Argentina	2	50 0.5×	15 0.5×	13 0.5×	8 1.1×	1 0.2×	2	54
Alexandra Kozedub United States	2	33 0.4×	21 0.6×	22 0.8×	9 1.3×		2	41
Marc Lévy France	4	70 0.8×	34 1.0×	15 0.5×	6 0.9×		11	91
Hal Joseph United States	3	38 0.4×	16 0.5×	21 0.8×	4 0.6×		6	45
Maria Spall United States	2	26 0.3×	20 0.6×	24 0.9×	5 0.7×		2	33
Klaus Busch Germany	3	158 1.7×	64 1.9×	50 1.8×	25 3.6×		3	163
Thy Khue Nguyen Singapore	2	73 0.8×	8 0.2×	17 0.6×	11 1.6×		3	78
Kim Englert United States	3	31 0.3×	23 0.7×	18 0.6×	2 0.3×		4	46
David W. Hansen United States	3	24 0.3×	16 0.5×	21 0.8×	5 0.7×		8	30

Countries citing papers authored by Sreenivasa Murthy

Since Specialization

Citations

This map shows the geographic impact of Sreenivasa Murthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sreenivasa Murthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sreenivasa Murthy more than expected).

Fields of papers citing papers by Sreenivasa Murthy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sreenivasa Murthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sreenivasa Murthy. The network helps show where Sreenivasa Murthy may publish in the future.

Co-authorship network of co-authors of Sreenivasa Murthy

This figure shows the co-authorship network connecting the top 25 collaborators of Sreenivasa Murthy. A scholar is included among the top collaborators of Sreenivasa Murthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sreenivasa Murthy. Sreenivasa Murthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Blevins, Thomas, Dominik Dahl, Federico Pérez Manghi, et al.. (2025). Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial. The Lancet. 405(10497). 2290–2301. 4 indexed citations

2.

Murthy, Sreenivasa. (2024). Deep Learning Classification using MRI for Alzheimer’s Disease Detection. International Scientific Journal of Engineering and Management. 3(4). 1–9. 1 indexed citations

3.

Ramadass, Balamurugan, et al.. (2024). Fixed-Dose Combination of Canagliflozin and Metformin as an Adjunct to Diet and Exercise in Indian Adults with Type 2 Diabetes Mellitus: Results from a Multicentric, Open-Label, Single-Arm, Phase IV Study. Journal of the Association of Physicians of India. 72(4). 13–20.

4.

Murthy, Sreenivasa, et al.. (2024). Enhancing the Security by Analyzing the Behavior of Multiple Classification Algorithms with Dimensionality Reduction to Obtain Better Accuracy. 783–790.

5.

Mathieu, Chantal, Björg Ásbjörnsdóttir, Harpreet S. Bajaj, et al.. (2023). Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial. The Lancet. 401(10392). 1929–1940. 86 indexed citations breakdown →

6.

Zargar, Abdul Hamid, Sanjay Kalra, Sreenivasa Murthy, et al.. (2022). Rising cost of insulin: A deterrent to compliance in patients with diabetes mellitus. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 16(8). 102528–102528. 5 indexed citations

7.

Murthy, Sreenivasa, et al.. (2021). Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market. PharmacoEconomics - Open. 5(2). 261–273. 2 indexed citations

8.

Murthy, Sreenivasa, et al.. (1979). Growth retardation and change in organ weights due to aflatoxicosis in rats and guineapigs.. PubMed. 56(4). 279–83. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact